ClinicalTrials.Veeva

Menu

Eating Disorders Genetics Initiative 2 (EDGI2)

University of North Carolina (UNC) logo

University of North Carolina (UNC)

Status

Enrolling

Conditions

Avoidant Restrictive Food Intake Disorder
Binge-Eating Disorder
Bulimia Nervosa
Anorexia Nervosa

Treatments

Other: Eating disorder diagnosis group

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT06594913
23-2887
R01MH136156 (U.S. NIH Grant/Contract)
R01MH136149 (U.S. NIH Grant/Contract)
R01MH136157 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The overarching intention of the Eating Disorder Genetics Initiative 2 (EDGI2) is to increase sample size, diversity, and eating disorder phenotypes. The investigators are enrolling 20,000 new participants with anorexia nervosa (AN), bulimia nervosa (BN), binge-eating disorder (BED), avoidant/restrictive food intake disorder (ARFID), and controls in the US, Mexico, Australia, New Zealand, Sweden, and Denmark. A primary study goal is to enroll at least 30% of participants from underrepresented groups. Participants are asked to complete a series of questionnaires and submit a saliva sample for genotyping. The goal is to better understand eating disorders and how they relate to each other so that better treatments can be developed.

Enrollment

20,000 estimated patients

Sex

All

Ages

12 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • A lifetime history of anorexia nervosa, bulimia nervosa, binge-eating disorder, avoidant restrictive food intake disorders or no history of any disordered eating behavior, based on DSM-5 criteria algorithms
  • Age 12-99 years, depending on country. (US enrollment age is 18-99)

Exclusion criteria

  • History of subthreshold disordered eating behaviors.

Trial design

20,000 participants in 5 patient groups

Anorexia nervosa
Description:
Individuals with a self-reported lifetime history of anorexia nervosa.
Treatment:
Other: Eating disorder diagnosis group
Bulimia nervosa
Description:
Individuals with a self-reported lifetime history of bulimia nervosa.
Treatment:
Other: Eating disorder diagnosis group
Binge-eating disorder
Description:
Individuals with a self-reported lifetime history of binge-eating disorder.
Treatment:
Other: Eating disorder diagnosis group
ARFID
Description:
Individuals with a self-reported lifetime history of avoidant restrictive food intake disorder.
Treatment:
Other: Eating disorder diagnosis group
Control
Description:
Individuals with no history of disordered eating behaviors or symptoms
Treatment:
Other: Eating disorder diagnosis group

Trial contacts and locations

5

Loading...

Central trial contact

Casey MacDermod, BA; Laura M Thornton, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems